Lippo Valuation

Is 226 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 226 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 226's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 226's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 226?

Key metric: As 226 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 226. This is calculated by dividing 226's market cap by their current revenue.
What is 226's PS Ratio?
PS Ratio	0.4x
Sales	HK$836.63m
Market Cap	HK$350.14m

226 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	6.2x
Enterprise Value/EBITDA	-130x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 226's PS Ratio compare to its peers?

The above table shows the PS ratio for 226 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.9x
2321 Swang Chai Chuan	0.2x	n/a	HK$370.1m
1936 Ritamix Global	1.6x	n/a	HK$322.2m
1587 Shineroad International Holdings	0.3x	n/a	HK$244.8m
8476 Ocean One Holding	1.5x	n/a	HK$635.6m
226 Lippo	0.4x	n/a	HK$350.1m

Price-To-Sales vs Peers: 226 is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (0.9x).

Price to Sales Ratio vs Industry

How does 226's PS Ratio compare vs other companies in the HK Consumer Retailing Industry?

5 Companies	Price / Sales	Estimated Growth	Market Cap
9886 Dingdang Health Technology Group	0.1x	13.1%	US$93.61m
980 Lianhua Supermarket Holdings	0.02x	n/a	US$57.53m
814 Beijing Jingkelong	0.01x	n/a	US$16.95m
759 CEC International Holdings	0.07x	n/a	US$12.41m

5 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 226 is good value based on its Price-To-Sales Ratio (0.4x) compared to the Hong Kong Consumer Retailing industry average (0.6x).

Price to Sales Ratio vs Fair Ratio

What is 226's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

226 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.4x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 226's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.